About
Epofit Recombinant Human Erythropoietin Alfa Injection 10000 IU is a top-rated biotechnology product designed to treat anaemia with redoubtable potency. Personalise patient care by exploring its therapeutic efficacy, as this dazzling haematopoietic agent stimulates erythropoiesis efficiently. Each 1 ml sterile vial contains a potent dose of Recombinant Human Erythropoietin Alfa, intended for intravenous or subcutaneous administration. Specially formulated for hospital and clinical use, its clear, colorless, odorless solution ensures optimal safety. Epofit is export-ready, prescription-only, and supplied with stringent quality standards, making it a reliable choice across India and global markets.
Application Method and Features
Epofit Recombinant Human Erythropoietin Alfa Injection 10000 IU is administered via intravenous or subcutaneous routes, ensuring rapid absorption and therapeutic effect. The sterile vial is ideal for hospital or clinical use, with application on suitable skin surfaces by trained professionals. This clear, colorless solution is odorless and retains enzymatic activity to stimulate erythropoiesis. Strict storage at 2C - 8C maintains its efficacy. Its prescription-only status ensures safe, regulated use for optimal patient benefit.
Export Markets and Sampling Information
Epofit Injection 10000 IU is widely exported, with India serving as the main supplier and FOB Port for international orders. Sample availability allows clients to evaluate product quality before placing a Purchase Order. Efficient freight management guarantees safe drop-off and timely delivery to global destinations. The product is designed to meet international standards, catering to hospitals and clinics in various markets for therapeutic use. Clients can request samples to ensure satisfaction prior to bulk purchases.
FAQ's of Epofit Recombinant Human Erythropoietin Alfa Injection 10000 IU:
Q: How is Epofit Recombinant Human Erythropoietin Alfa Injection 10000 IU administered?
A: Epofit is administered intravenously or subcutaneously by trained healthcare professionals, typically in hospital or clinical settings. Proper technique ensures optimal absorption and therapeutic effect.
Q: What indications is Epofit Injection 10000 IU used for?
A: Epofit is indicated for the treatment of anaemia as a haematopoietic agent, stimulating erythropoiesis to increase red blood cell production.
Q: Where should Epofit Injection be stored for maximum efficacy?
A: This product should be stored at a temperature of 2C to 8C to maintain sterility and effectiveness throughout its 36-month shelf life.
Q: When can samples of Epofit Injection 10000 IU be requested for evaluation?
A: Samples are available upon request, allowing purchasers and medical facilities to evaluate the product before making a bulk Purchase Order.
Q: What is the benefit of choosing Epofit for clinical use?
A: Epofit offers potent therapeutic action, high purity, and reliable performance, making it a preferred option in hospitals and clinics for managing anaemia.
Q: How does Epofit Injection stimulate erythropoiesis?
A: Epofit contains Recombinant Human Erythropoietin Alfa, which activates the bone marrow to produce more red blood cells, effectively combating anaemia.